Evidence map›Paper›PMID 33117894›Full record

SynthesisWellcome open research2020

A living mapping review for COVID-19 funded research projects: final (27 month) update.

Adrian Bucher, Emilia Antonio, Nusrat Jabin, Chantel Jones, Andrea Padilla, Susan Khader, Genevieve Boily-Larouche, Morgan Lay, Alice Norton

Abstract readSystematic Review
In one paragraph

Synthesis in Wellcome open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Tapping into the minds and hearts of the local public health workforce during the COVID-19 pandemic.Canadian journal of public health = Revue canadienne de sante publique · 2022
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adrian BucherUK Collaborative on Development Research, London, UK.
Emilia AntonioGloPID-R, Pandemic Sciences Institute, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-9375-6936
Nusrat JabinUK Collaborative on Development Research, London, UK.
Chantel JonesUK Collaborative on Development Research, London, UK.
Andrea PadillaUK Collaborative on Development Research, London, UK.
Susan KhaderGloPID-R, Pandemic Sciences Institute, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-2078-0097
Genevieve Boily-LaroucheInstitute of Infection and Immunity, Canadian Institutes of Health Research, Hamilton, Canada.
Morgan LayInstitute of Population and Public Health, Canadian Institutes of Health Research, Toronto, Canada.
Alice NortonGloPID-R, Pandemic Sciences Institute, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0001-8908-2775

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 (COVID-19) has resulted in an unprecedented research response, demonstrating exceptional examples of rapid research and collaboration. There has however been an ongoing need for greater coordination, with limited resources for research and the shifting global pandemic.

methodsThe UK Collaborative on Development Research (UKCDR) and Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), two funder coordination groups have collaborated to develop a live database of funded research projects across the world relating to COVID-19. Drawing data continually from their members and further global funding bodies, as of 15th October 2022 the database contains 20,006 projects, funded by 351 funders, taking place across 157 countries representing an investment of at least $7.4 billion. To our knowledge it is one of the most comprehensive databases. The database is aligned to the World Health Organisation and GloPID-R Global Research Roadmap: 2019 Novel Coronavirus and the UN Research Roadmap for the COVID-19 Recovery. It is being used by the WHO, governments and further policy makers, research funders and researchers. This living mapping review aims to supplement the database by providing an open, accessible, and frequently updated resource summarising the characteristics of the COVID-19 funded research portfolio. Both descriptive and thematic analyses are presented and updated frequently to aid interpretation of the global COVID-19 funded research portfolio.

resultsIn this final version ten analysis, we provide an updated detailed descriptive analysis of the database (on data from three months after version nine) and focus our thematic analysis on research gaps, research areas in need of coordination, study populations, and research locations (with a focus on resource-limited countries).

conclusionsAs the global research response to COVID-19 plateaus, this living mapping review has helped both funders and researchers to prioritise resources and review investments.

Indexed as

coordinationCoronavirusCOVID-19global health policyLiving systematic reviewresearch funding

Identifiers

PMID33117894
PMCPMC7579366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.